1 Introduction

Due to medical science's failure to provide a complete treatment for cancer disorders, cancer diagnosis research has gotten a lot of attention during the previous several decades all over the world. These malignant cells grow abnormally and form tumours, which can be detected by a variety of medical tests. To reduce the deadly effects of cancer, it is critical to discover it at an early stage and to do so, a variety of clinical investigations are available in healthcare organisations to anticipate the current cell report (Katz and Edelson 2009). However, understanding the optical, chemical, and mechanical properties of a living cancer cell can lead to numerous interesting new insights into the cell's biology (Suresh 2007). The interaction of light with cells has recently yielded useful knowledge about changes in the optical characteristics of various cells. Most crucially, the cell's refractive index has gotten a lot of attention, which has expanded the possibilities for detecting cell abnormalities. According to cancer science, normal cells' refractive indices are lower than cancerous cells, which can be used as a useful indicator in the identification and diagnosis of malignant cells (Backman et al. 2000).

Photonic sensors are specifically intended to detect a variety of bio analytes by successfully converting the bio-entity into an electrical form that can be examined using a spectrometer (Danaie and Kiani 2018). Electrical characteristics and electric field analysis are used to examine the differences between normal and malignant cells (Panda and Devi 2020). Furthermore, the refractive indices of various analytes emerge as a critical parameter in the development of precise biosensors (Derbali et al. 2011; Vijayalakshmi et al. 2021; Islam et al. 2021). Recently, a few studies have been published that are based on the tabular optical properties of a variety of tissues, but this table may not provide enough information about living cells. The effective refractive index of discrete live cells has been determined using several optical (Bashkatov et al. 2011; Kim and Wilson 2011) approaches such as solution matching (Barer 1957) and refractometry analysis (Lue et al. 2006). Even though the aforementioned references reveal fascinating results, the paucity of research on the cell's local refractive index is a matter of concern. Furthermore, the sensing devices and procedures are somewhat sophisticated in terms of design, making them challenging to implement in practice. Apart from that, none of the studies in the literature has looked at sensor sensitivity, resolution, quality factor, and nonlinear coefficient all at the same time. Furthermore, the aforementioned sensor measurement parameters are insufficient to satisfy the current sensing scenario's difficulty. Although there are various strategies for detecting cancer cells in the literature, the current study is based on an examination of a binary photonic crystal for detecting normal and cancerous cells in a short amount of time. In a recent work, the authors have analysed the sensing of cancerous cells by investigating electric field distribution in a simple 2D photonic crystal fiber structure. Two clusters of cell lines, human immortalized normal oral keratinocyte which in normal cells group and YD-10B cells which are cancerous, were considered (Woo June Choi 2010). In a recent study, early cancer cell detection has been investigated by using an SPR-based photonic crystal fiber (PCF) biosensor structure (Yasli 2021). For numerical analysis, the finite element method with properly matched layers is used. The refractive index fluctuations of cancer cells are detected using spectral interrogation and amplitude approaches. Mollah et al. have presented a twin-core PCF for early detection of blood cancer based on the variation of the refractive index between normal and cancerous blood cells (Aslam Mollah et al. 2020). The analytes of the cancerous and normal cells have been considered at 80% and 30–70% in liquid form, respectively. The samples have been infiltrated into the central air hole. Using the finite element method, the change in the coupling length and transmitted spectrum of the proposed biosensor for normal and malignant cells have been observed. A metamaterial biosensor based on two loops of hexagonal gold layers on a polyamide substrate has been proposed for cancer cell early detection (Azab et al. 2021). Dual-core PCFs have been proposed (Ayyanar et al. 2018; Gyan Prakash Mishra 2020) for the detection of cancer cells in cervical, breast and basal parts.

In this work, simple methodologies and compact structures are employed which can be easily implemented with newly emerging technologies. Normal cells, as well as five caner cells, are considered. Jurkat, Hela, PC12, MDA-MB231 and MCF-7 cancer cells are treated as analytes. The sensor performance parameters are all considered such as quality factor, figure of merit, detection limit, detection accuracy, signal-to-noise ratio, standard deviation, sensor resolution and dynamic range to enhance the novelty of the current research.

2 Design and theoretical model

One-dimensional (1D) binary defective photonic crystal is proposed for cancer cell detection as shown in Fig. 1. The photonic crystal has the structure (AB)N/D/(AB)N. Layers A and B are chosen as Si and SiO2, respectively. D is the defect layer which is either a normal or cancerous cell. Layer D lies midway between two identical period numbers (N). The thicknesses and refractive indices of the layers are d1, d2 and dD and n1, n2, and nD, for Si, SiO2 and the defect layers, respectively.

Fig. 1
figure 1

Schematic diagram of 1D binary photonic crystal having a cancer cell as a defect layer

A wide choice of different techniques to simulate photonic crystals is described in the literature. In the specific case of 1D photonic crystals, the transmission spectrum can be simulated using many different numerical methods such as finite difference time domain methods and finite element methods. The transfer matrix method is a simple and flexible technique to analyze the optical properties of 1D photonic crystals. We consider a system consisting of air/multilayer/substrate. The parameters related to air and substrate media are just their refractive indexes, no and ns, respectively. With Es and Hs are the electric and magnetic fields in the substrate, we can write the incident fields (E0 and H0) in terms of Es and Hs as

$$\left[ {\begin{array}{*{20}c} {{\text{E}}_{0} { }} \\ {{\text{H}}_{0} } \\ \end{array} } \right] = \mathop \prod \limits_{j = 1}^{N} F_{j} \left[ {\begin{array}{*{20}c} {\text{Es }} \\ {\text{ Hs}} \\ \end{array} } \right] = \left[ {\begin{array}{*{20}c} {f_{11} } & {f_{12} } \\ {f_{21} } & {f_{22} } \\ \end{array} } \right]\left[ {\begin{array}{*{20}c} {\text{Es }} \\ {\text{ Hs}} \\ \end{array} } \right]$$
(1)

where \({F}_{j}\) is the characteristic matrix of one layer and fij are the matrix elements. Fj can be written as

$$F_{j} = \left[ {\begin{array}{*{20}c} {\cos \left( {\delta_{j} } \right)} & { - \frac{{i \sin \left( {\delta_{j} } \right)}}{{\gamma_{j} }}} \\ { - i\gamma_{j} \sin \left( {\delta_{j} } \right)} & {\cos \left( {\delta_{j} } \right)} \\ \end{array} } \right]$$
(2)

\({\delta }_{j}\) is the phase variation of the light wave due to propagating through the jth layer

$$\delta_{j} = \frac{2\pi }{\lambda }n_{j} d_{j} \cos \theta_{j}$$
(3)

where \({n}_{j}\), dj \({\theta }_{j}\) are the refractive index, thickness and angle of incidence of the layer. \({\theta }_{j}\) can be written in terms of the initial incidence angle \({\theta }_{0}\) as

$$\cos \theta_{j} = \sqrt {1 - \left( {\frac{{n_{0} {\text{ sin}}\left( {\theta_{0} } \right)}}{{n_{j} }}} \right)^{2} }$$
(4)

\({\gamma }_{j}={n}_{j}\mathrm{cos}({\theta }_{j})\) in transverse electric (TE) wave whereas \({\gamma }_{j}=\mathrm{cos}({\theta }_{j})/{n}_{j}\) in transverse magnetic (TM) wave and \({n}_{0}\) is the refractive index of the incidence medium. The transfer matrix F0 for one period consisting of two layers A and B can be written as F0 = FA FB. The full transfer matrix F of a defective binary photonic crystal can be expressed as

$$F = \left( {F_{0} } \right)^{N} F_{D} \left( {F_{0} } \right)^{N} = \left[ {\begin{array}{*{20}c} {F_{11} } & {F_{12} } \\ {F_{21} } & {F_{22} } \\ \end{array} } \right]$$
(5)

where FD is the transfer matrix of the defect layer and Fij are the elements of the total transfer matrix F.

The transmission coefficient can be written as

$$t=\frac{2{\gamma }_{in}}{\left({F}_{11}+{F}_{12}{ \gamma }_{out}\right){\gamma }_{in}+({F}_{21}+{F}_{22 }{\gamma }_{out})}$$
(6)

and the transmittance can have the form

$$T=\frac{{\gamma }_{out}}{{\gamma }_{in}}{\left|t\right|}^{2}$$
(7)

The reflection coefficient can be written as

$$r=\frac{\left({F}_{11}+{F}_{12}{\gamma }_{out}\right){\gamma }_{in}-({F}_{21}+{F}_{22}{\gamma }_{out})}{\left({F}_{11}+{F}_{12}{\gamma }_{out}\right){\gamma }_{in}+({F}_{21}+{F}_{22}{\gamma }_{out})}$$
(8)

and the reflectance can have the form

$$R={\left|r\right|}^{2}$$
(9)

For transverse electric (TE) waves, \({\gamma }_{in}={\gamma }_{out}= \mathrm{cos}({\theta }_{0})\) since the binary photonic crystal is assumed to be surrounded by air.

Based on the above theoretical equations, properties of both photonic bandgap and defect mode of a defective binary photonic crystal can be investigated.

3 Results and discussion

3.1 Cancer cell sensor

A binary photonic crystal is assumed with the structure (Si/SiO2)N/D/(Si/SiO2)N whose refractive indices are 3.3 for the Si and 1.46 for the SiO2. The thicknesses of the layers are taken as \({d}_{1}=117 \mathrm{nm}\) and \({d}_{2}=265\) nm, respectively. The wavelength of the incident radiation is taken from 800 to 2300 nm and the number of periods is taken as N = 5. The transfer matrix method is employed to treat the current problem. A code is generated using WOLFRAM MATHEMATICA 11.2 software to find the reflectance profile. All the above equations are fed to the Mathematica code. OriginPro 8.5 is used to plot the figures. Normal incidence is first considered in which θ0 = 0 and D is either the normal or cancerous cell. The transmission spectrum through the proposed binary photonic crystal without any defect layer is shown in Fig. 2a. A photonic bandgap of a width of 890 nm can be seen with left and right edges at wavelengths of 1221 nm and 2111, respectively. Figure 2b shows the transmission spectrum through the structure when the normal cell layer of thickness 1D is treated as a defect layer, where D = d1 + d2 (d1 = 117 nm, d2 = 265 nm). The width of the photonic bandgap becomes 1016.01 nm where the left and right edges are at wavelengths of 1202 nm and 2218.01 nm, respectively. A defect mode can be seen in the figure at a resonant wavelength of 1685.54 nm. An enlarged view of the defect mode is plotted in Fig. 2c when the normal cell layer is treated as a defect layer. The full width at half maximum of the resonant peak is \(FWHM=0.45 nm\) where the wavelengths of left and right edges are 1685.31 nm and 1685.76 nm. The quality factor (QF) is found as 3745.64 which was calculated by the following equation:\(QF=\frac{{\lambda }_{peak}}{FWHM}\), where \({\lambda }_{peak}\) is the resonant wavelength.

Fig. 2
figure 2

Transmission spectra of a binary photonic crystal without a defect layer (a), with a defect layer (b) and an enlarged view of the defect mode (c) for TE wave at θ0 = 0.0°, d1 = 117 nm, d2 = 265 nm, n1 = 3.3, n2 = 1.46 and N = 5

Figure 3 shows the transmission spectra through the binary photonic crystal when the cancerous cells are treated as defect layers. It is found that the resonant peak shifts to a higher wavelength region. The new wavelength positions of the defect mode are cell-dependent. The new wavelength positions are at 1702.92, 1703.8, 1705.10, 1706.85 and 1707.71 nm for Jurkat, Hela, PC12, MDA-MB231 and MCF-7 cells, respectively. The sensitivity can be calculated as \(\frac{\Delta \lambda }{\Delta n}\), where \(\Delta \lambda\) is the wavelength shift between the resonant peak position of the normal cell and cancer cell and \(\Delta n\) is the change of refractive index between the normal cell and cancer cell. The sensitivity was found as 434.5, 434.76, 434.66, 434.89 and 434.70 nm/RIU for the cells of Jurkat, Hela, PC12, MDA-MB231 and MCF-7, respectively. Table 1 presents the refractive indices of different cancerous cells, defect mode positions of each cell and sensitivity of the proposed binary photonic crystal to each cell.

Fig. 3
figure 3

Transmission spectra of a binary photonic crystal for TE wave at θ0 = 0.0°, d1 = 117 nm, d2 = 265 nm, n1 = 3.3, n2 = 1.46, d = 1D and N = 5

Table 1 Defect mode position and sensitivity of the cancerous cells at θ0 = 0.0°, d1 = 117 nm, d2 = 265 nm, n1 = 3.3, n2 = 1.46, d = 1D and N = 5

3.2 Effect of the incident angle

3.2.1 Angle of incidence and sensitivity

The incident angle variation has an essential effect on the bandgap position according to the Bragg-Snell law (Dalmisa et al. 2019)

$$m\lambda = 2d\sqrt {n_{eff}^{2} - \sin^{2} \theta_{0} }$$
(10)

where m, \(\lambda\), d, \({\theta }_{0}\) and \({n}_{eff}\) are the order of diffraction (m is an integer), the free space wavelength, the interplanar spacing, the incident angle and the effective refractive index, respectively. The angle of incidence was changed from 0° to 89° in steps of 5°. The results for two angles of them are presented in Tables 2 and 3 which show the enhancement of sensitivity from 496.77 nm/RIU to 671.23 nm/RIU when the incident angle increases from 30° to 60°.

Table 2 Defect mode position and sensitivity of the cancerous cells at an incidence angle of θ0 = 30°
Table 3 Defect mode position and sensitivity of the cancerous cells at an incidence angle of θ0 = 60°

In Table 4, we calculated the average sensitivity of the proposed binary photonic crystal corresponding to different incident angles starting from θ0 = 0° to θ0 = 89° with an increment of 5°. The sensitivity attains a considerable enhancement as the incident angle increases from 0° to 85°. For further increase of the angle of incidence beyond 85°, insignificant enhancement of the sensitivity can be observed. So, the angle of 85° is taken as the optimum value of the incident angle. The relation between the sensitivity (S) to cancer cells and the incident angle (\({\theta }_{0}\)) of a proposed binary photonic crystal is shown in Fig. 4 (blue points). It can be fitted by the following equation

Table 4 Effect of the incident angle on the sensitivity of the cancerous cells at d = 1D and N = 5
Fig. 4
figure 4

Sensitivity with the angle of incidence of a binary photonic crystal for TE wave at d1 = 117 nm, d2 = 265 nm, n1 = 3.3, n2 = 1.46, d = 1D and N = 5

$$S\left({\theta }_{0}\right)=434.08\text{\hspace{0.05em}}+0.3482{\theta }_{0}+0.03322{\theta }_{0}^{2}+1.17{\theta }_{0}^{3}-1.2131\times {10}^{-5}{\theta }_{0}^{4}$$
(11)

The fitting Eq. (11) is useful to predict the sensitivity of the cancer cell sensor at any value of the incident angle located between \({\theta }_{0}=0.0^\circ\) and \({\theta }_{0}=85^\circ\). The fitted sensitivity as a function of the incident angle (red curve) along with the data (blue points) is shown in Fig. 4. The matching between the data and the fitting equation is perfect.

3.2.2 Angle of incidence and photonic bandgap

The photonic bandgap can be explained by the transmission of light through certain frequencies is zero by multiple Bragg scattering. The results in Table 5 show that as the incident angle increases, the photonic bandgap width increases. At an incident angle of 0.0°, the photonic bandgap width is 1016.01 nm. When the incident angle increases to 89°, the photonic bandgap width increases to 1094.7 nm. The photonic bandgap width versus the incident angle is shown in Fig. 5. The photonic bandgap width is calculated as the difference between the wavelengths of the left and right edges at half maximum of transmission in nanometers.

Table 5 Effect of the incident angle on the width of bandgap at d = 1D and N = 5
Fig. 5
figure 5

Width of bandgap versus the incident angle of a binary photonic crystal for TE wave at d1 = 117 nm, d2 = 265 nm, n1 = 3.3, n2 = 1.46, d = 1D and N = 5

The sensitivity enhancement with the increase of the incident angle can be attributed to the increase of the photonic bandgap with the increase of the incident angle. As the photonic bandgap increases, the emergence and shift of the resonant wavelength are more likely.

3.3 Effect of the number of periods

The number of periods of a photonic crystal can affect the sensitivity and bandgap width of a binary photonic crystal.

3.3.1 Number of periods and sensitivity

The number of periods was changed from 3 to 7. Some of the results can be seen in Tables 6 and 7. The average sensitivity has dropped from 444.45 nm/RIU to 434.27 nm/RIU as the number of periods increases from 3 to 6. The resonant peak position is 1687.65 nm when the normal cell is treated as a defect layer at a number of periods of 3. But when the cancerous cells are treated as defect layers, it is found that the resonant peak shifts to a higher wavelength region (redshift) as shown in Fig. 6. The new wavelength positions are at 1705.44, 1706.31, 1707.66, 1709.41and 1710.32 nm for Jurkat, Hela, PC12, MDA-MB231 and MCF-7 cells, respectively. The sensitivity is calculated and found as 444.75, 444.28, 444.66, 444.08 and 444.50 nm/RIU for the cells of Jurkat, Hela, PC12, MDA-MB231 and MCF-7, respectively.

Table 6 Defect mode position and sensitivity of the cancerous cells at a number of periods N = 3
Table 7 Defect mode position and sensitivity of the cancerous cells at a number of period N = 6
Fig. 6
figure 6

Transmission spectra of a binary photonic crystal for TE wave at θ0 = 0.0°, d1 = 117 nm, d2 = 265 nm, n1 = 3.3, n2 = 1.46, d = 1D and N = 3

Table 8 shows that as the number of periods increases, the sensitivity of the biosensor decreases. This can be attributed to the fraction of light in the analyte layer being less when the number of periods increases. The relation between the sensitivity of the cancer cell sensor (S) and the number of periods (\(\mathrm{N}\)) of a proposed binary photonic crystal can be fitted by the following equation

Table 8 Effect of the number of periods on the sensitivity of the cancerous cells at d = 1D and θ0 = 0°
$$S\left(N\right)=644.05\text{\hspace{0.05em}}-149.028N+39.6608{N}^{2}-4.66667{N}^{3}+0.204167{N}^{4}$$
(12)

The fitting Eq. (12) can predict the sensitivity of the cancer cell sensor at any value of the number of periods located between \(N=3\) and \(\mathrm{N}=7\). When the number of periods increases beyond N = 7, the defect mode starts vanishing. The fitting equation of the sensitivity as a function of the number of periods (red curve) along with the data (blue points) is shown in Fig. 7. The matching between the data and the fitting equations is perfect.

Fig. 7
figure 7

Sensitivity versus the number of periods of a binary photonic crystal for TE wave at d1 = 117 nm, d2 = 265 nm, n1 = 3.3, n2 = 1.46, θ0 = 0.0° and d = 1D

3.3.2 Number of periods and photonic bandgap

Table 9 presents the bandgap width of the proposed binary photonic crystal and the wavelength positions of the left and right edges at different N starting from N = 3 to N = 10. When the number of periods increases the photonic bandgap width decreases. For a binary photonic crystal of N = 3, the photonic bandgap width is 1246 nm. When N becomes 10, the photonic bandgap width decreases to 889.4 nm. When N is less than 3, the photonic bandgap cannot be observed. The bandgap width versus the number of periods is shown in Fig. 8.

Table 9 Effect of the number of periods on the bandgap width at d = 1D and θ0 = 0°
Fig. 8
figure 8

Width of bandgap versus the number of periods of a binary photonic crystal for TE wave at d1 = 117 nm, d2 = 265 nm, n1 = 3.3, n2 = 1.46, θ0 = 0.0° and d = 1D

3.4 Effect of cancer cell layer thickness

3.4.1 Cancer cell layer thickness and sensitivity

The cancer cell layer thickness was changed from 1 to 13D. Some of the results can be seen in Tables 10 and 11. The average sensitivity has risen from 434.7 to 802.55 nm/RIU as the cancer cell layer thickness increases from 1 to 4D. Increasing the cancer cell layer from 7 to 13D shows a kind of saturation. A further increase of the cancer cell layer beyond 13D shows an insignificant improvement in the sensitivity.

Table 10 Defect mode positions and sensitivity at a cancer cell layer thickness of 1D
Table 11 Defect mode positions and sensitivity at a cancer cell layer thickness of 4D

Table 12 shows that as the cancer cell layer thickness increases the sensitivity of the biosensor is dramatically enhanced. In optimizing the proposed sensor, we consider the cancer cell layer thickness to be 13D. The relation between the sensitivity and the cancer cell layer thickness of a proposed binary photonic crystal can be fitted by the following equation

Table 12 Effect of the cancer cell layer thickness on the cancerous cell sensitivity at θ0 = 0° and N = 5
$$S\left({d}_{f}\right)=201.7+0.62{d}_{f}-1.7046\times {10}^{-4}{d}_{f}^{2}+2.2\times {10}^{-8}{d}_{f}^{3}-1.01\times {10}^{-12}{d}_{f}^{4}$$
(13)

The fitted sensitivity as a function of cancer cell layer thickness (red curve) along with the data presented in Table 12 (blue points) is shown in Fig. 9. The matching between the calculated data and the fitting equations is excellent.

Fig. 9
figure 9

Sensitivity versus the cancer cell layer thickness of a binary photonic crystal for TE wave at d1 = 117 nm, d2 = 265 nm, n1 = 3.3, n2 = 1.46, θ0 = 0° and N = 5

3.4.2 Cancer cell layer thickness and photonic bandgap

Table 13 shows that the photonic bandgap width oscillates as the cancer cell layer thickness increases. For example, as the cancer cell layer thickness increases from 1 to 2D, the photonic bandgap width decreases from 1018 to 905.2 nm and as the layer thickness increases from 2 to 3D, the photonic bandgap width increases from 905.2 to 1024 nm. The photonic bandgap width versus the cancer cell layer thickness is plotted in Fig. 10.

Table 13 Effect of the cancer cell layer thickness on the bandgap width at θ0 = 0° and N = 5
Fig. 10
figure 10

Width of bandgap versus the cancer cell layer thickness of a binary photonic crystal for TE wave at d1 = 117 nm, d2 = 265 nm, n1 = 3.3, n2 = 1.46, θ0 = 0° and N = 5

3.5 Cancer cell sensor optimization

Figure 11 shows the defect modes corresponding to different cells at the sensitivity optimized conditions (θ0 = 85°, \({d}_{f}\) = 13D and N = 3). When the normal cell is treated as a defect layer, the resonant peak position is at 1855.05 nm. It is found that resonant peak shifts to a higher wavelength region as cancerous cells are treated as defect layers. The new wavelength positions of the defect mode are cell-dependent. The new wavelength positions are at 1951.62, 1956.25, 1963.11, 1972.8 and 1976.68 nm for Jurkat, Hela, PC12, MDA-MB231 and MCF-7 cells, respectively. The sensitivity is found as 2414.25, 2409.52, 2401.4, 2390.4 and 2384.9 nm/RIU for the cells of Jurkat, Hela, PC12, MDA-MB231 and MCF-7, respectively. Table 14 presents the refractive indices of different cancerous cells, the defect mode positions of each and the sensitivity of the proposed binary photonic crystal to each cell.

Fig. 11
figure 11

Transmission spectra of a binary photonic crystal for TE wave at θ0 = 85°, d1 = 117 nm, d2 = 265 nm, n1 = 3.3, n2 = 1.46, d = 13D and N = 3

Table 14 Defect mode position and sensitivity of the cancerous cells at θ0 = 85°, d = 13D and N = 3

To show the efficiency of the proposed sensor, we calculated some performance parameters such as quality factor, figure of merit, detection limit, detection accuracy, signal-to-noise ratio, standard deviation, sensor resolution and dynamic range (Ahmed and Shaban 2020; Ahmed et al. 2021). Table 15 shows the calculated values of the sensor performance parameters.

Table 15 Performance parameters of the cancer cell sensor at optimized conditions (θ0 = 85°, d = 12D and N = 3)
$$QF=\frac{{\lambda }_{peak}}{FWHM}$$
(14)
$$FOM=\frac{S}{FWHM}=\frac{\Delta \lambda }{\Delta n*FWHM }$$
(15)
$$DL={\left(\frac{FWHM}{\Delta \lambda }\right) }^\frac{5}{4} \left(\frac{2 \Delta n}{3}\right)$$
(16)
$$DA=\frac{1}{FWHM}$$
(17)
$$SNR=\frac{\Delta \lambda }{FWHM}$$
(18)
$$\sigma =\left(\frac{2}{9}\right)\left(\frac{FWHM}{{SNR}^{1/4}}\right)$$
(19)
$$\mathrm{SR}=\mathrm{S}\boldsymbol{ }\left(DL\right)=\frac{\Delta\uplambda }{\Delta \mathrm{n}}\left(DL\right)$$
(20)
$$DR=\frac{{\lambda }_{peak}}{\sqrt{FWHM}}$$
(21)

Table 16 presents a comparison of the current work sensitivity with that of the most recent published biosensors. It shows the technique used and the sensitivity obtained. As can be seen, the current sensor achieves the highest sensitivity.

Table 16 Comparing the sensitivity of the current work with that of the most recent published biosensors

4 Conclusion

We have assumed a nano-detector using a 1D binary PC to detect cancerous cells. The effects of incident angle, number of periods and the defect layer thickness on the sensitivity and bandgap width of the proposed structure were investigated. By changing the blood sample from normal to cancer cells, the defect mode is shifted to a higher wavelength region. The sensitivity of the proposed design is considerably enhanced when the incidence angle and the defect layer thickness increase. The photonic bandgap width of the proposed binary photonic crystal increases when the incidence angle increases while it oscillates as the defect layer thickness increases. When the number of periods increases, both sensitivity as well as bandgap width decrease. The sensitivity reached 2400.08 nm/RIU at optimized conditions which is extremely high when compared to most recent papers published in the biosensing field. In addition, our sensor has a very simple structure, tunable design and low cost.

Finally, it is worth mentioning that the typical diameter of a human blood cell is around 7–8 μm. As a result, the defect layer thickness should be taken in this range to test the human cells efficiently. Moreover, the Thermo Scientific Multiskan SkyHigh Microplate Spectrophotometer is a good candidate that is capable of detecting the transmission in the proposed range. It is a spectrophotometer that is designed to be convenient and straightforward to use for virtually any photometric research application, including DNA, RNA, and protein detection as well as turbidity measurements.